|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Dermatopolymyositis, unspecified
ICD-10 (CM) Code and Descriptor
|
M33.90 |
Dermatopolymyositis, unspecified, organ involvement unspecified
|
M3390 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 60.87%
|
16.82%
|
8.41%
|
4.96%
|
2.98%
|
1.77%
|
1.49%
|
0.84%
|
0.58%
|
0.37%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M33.90*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96365
|
THER/PROPH/DIAG IV INF INIT |
6,150
|
6,154
|
|
96366
|
THER/PROPH/DIAG IV INF ADDON |
6,000
|
15,401
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
3,492
|
3,492
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,240
|
3,253
|
|
82550
|
ASSAY OF CK (CPK) |
3,220
|
3,220
|
|
J1561
|
GAMUNEX-C/GAMMAKED |
3,216
|
183,835
|
|
J1569
|
GAMMAGARD LIQUID INJECTION |
3,160
|
189,309
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
3,116
|
3,140
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,977
|
2,978
|
|
J1459
|
INJ IVIG PRIVIGEN 500 MG |
2,923
|
186,632
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
2,556
|
3,367
|
|
86140
|
C-REACTIVE PROTEIN |
1,987
|
1,987
|
|
85652
|
RBC SED RATE AUTOMATED |
1,690
|
1,690
|
|
82085
|
ASSAY OF ALDOLASE |
1,385
|
1,385
|
|
J1200
|
DIPHENHYDRAMINE HCL INJECTIO |
1,269
|
1,595
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,149
|
2,617
|
|
82565
|
ASSAY OF CREATININE |
787
|
787
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
613
|
26,352
|
|
J2930
|
METHYLPREDNISOLONE INJECTION |
583
|
1,234
|
|
Q0163
|
DIPHENHYDRAMINE HCL 50MG |
580
|
582
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M33.90 related to the following DRG Codes:
545-547
|
